1. Home
  2. PRTA vs BMBL Comparison

PRTA vs BMBL Comparison

Compare PRTA & BMBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • BMBL
  • Stock Information
  • Founded
  • PRTA 2012
  • BMBL 2014
  • Country
  • PRTA Ireland
  • BMBL United States
  • Employees
  • PRTA N/A
  • BMBL N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • BMBL Computer Software: Prepackaged Software
  • Sector
  • PRTA Health Care
  • BMBL Technology
  • Exchange
  • PRTA Nasdaq
  • BMBL Nasdaq
  • Market Cap
  • PRTA 765.2M
  • BMBL 828.7M
  • IPO Year
  • PRTA N/A
  • BMBL 2021
  • Fundamental
  • Price
  • PRTA $15.56
  • BMBL $5.21
  • Analyst Decision
  • PRTA Buy
  • BMBL Hold
  • Analyst Count
  • PRTA 8
  • BMBL 17
  • Target Price
  • PRTA $46.00
  • BMBL $7.91
  • AVG Volume (30 Days)
  • PRTA 336.3K
  • BMBL 3.7M
  • Earning Date
  • PRTA 02-20-2025
  • BMBL 02-18-2025
  • Dividend Yield
  • PRTA N/A
  • BMBL N/A
  • EPS Growth
  • PRTA N/A
  • BMBL N/A
  • EPS
  • PRTA N/A
  • BMBL N/A
  • Revenue
  • PRTA $135,157,000.00
  • BMBL $1,083,632,000.00
  • Revenue This Year
  • PRTA $56.89
  • BMBL $3.82
  • Revenue Next Year
  • PRTA N/A
  • BMBL N/A
  • P/E Ratio
  • PRTA N/A
  • BMBL N/A
  • Revenue Growth
  • PRTA 47.92
  • BMBL 6.26
  • 52 Week Low
  • PRTA $11.70
  • BMBL $4.80
  • 52 Week High
  • PRTA $31.03
  • BMBL $13.37
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 59.65
  • BMBL 22.02
  • Support Level
  • PRTA $13.69
  • BMBL $8.20
  • Resistance Level
  • PRTA $15.09
  • BMBL $8.64
  • Average True Range (ATR)
  • PRTA 0.91
  • BMBL 0.41
  • MACD
  • PRTA 0.13
  • BMBL -0.36
  • Stochastic Oscillator
  • PRTA 68.56
  • BMBL 0.82

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About BMBL Bumble Inc.

Bumble Inc is engaged in offering online dating services. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect.

Share on Social Networks: